Biotech firm Odyssey raises $279 million in upsized US IPO
Investing.com Gold reports: Biotech firm Odyssey raises $279 million in upsized US IPO. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Biotech firm Odyssey raises $279 million in upsized US IPO. Full body text was unavailable at ingest time, so this brief is based on headline context.